Non-Alcoholic Fatty Liver Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People between 25 and 55 years old
• People who are willing to sign a consent form agreeing to take part as a research participant
• People who are able and willing to take supplements by mouth at set times throughout the study
• People who are willing to keep a diary to record whether they have taken their supplements as instructed
• People who have been diagnosed with a liver condition called MAFLD (metabolic-associated fatty liver disease), confirmed by a specialist using a scan called FibroScan, with a specific fat measurement result (CAP score) of 263 dB/m or higher

Who may not be able to join:

• People who have hepatitis B, hepatitis C, autoimmune hepatitis, alcoholic liver disease, or liver cirrhosis
• People who are pregnant, breastfeeding, or planning to become pregnant during the study
• People with a history of drinking more than 40 grams of alcohol per day
• People who have had serious liver-related complications, including fluid build-up in the abdomen (ascites), brain function problems linked to liver disease (encephalopathy), or bleeding from swollen veins in the digestive tract
• People who have been diagnosed with liver cancer (hepatocellular carcinoma)
• People who have had bowel removal surgery or weight-loss surgery, or who have a chronic inflammatory bowel condition such as Crohn's disease or ulcerative colitis
• People who have taken antibiotics, probiotics, prebiotics, or synbiotics within the past month
• People who are currently using Vitamin E or omega-3 fatty acid supplements
• People who were not hospitalised in the past month and therefore had no dietary restrictions related to illness (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.